Developer of radiation therapy equipment intended to help cancer patients. The company focuses on the development of radiotherapy technology, radiotherapy products and services, providing clinical radiotherapy solutions for tumor treatment.
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. IPO | 31-Dec-2021 | Cancelled | Generating Revenue | |||
| 5. Later Stage VC | 24-Jun-2020 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
| 4. Later Stage VC | 16-May-2020 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
| 3. Later Stage VC | 24-Feb-2020 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
| 2. Later Stage VC | 27-Aug-2019 | $17.1M | $20M | 00000 | Completed | Generating Revenue |
| 1. Later Stage VC | 30-Jan-2019 | $2.94M | $2.94M | 00000 | Completed | Generating Revenue |
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210330990-A1 | Shielding apparatus | Pending | 03-Dec-2020 | 00000000 | |
| US-20210330991-A1 | Jaw assembly and medical accelerator | Pending | 26-Apr-2020 | 0000000000 | |
| US-20210293373-A1 | Rotating gantry and radiotherapy equipment | Pending | 20-Mar-2020 | 0000000000 | |
| US-20210295542-A1 | Method, radiotherapy device, and computer-readable storage medium for image registration | Pending | 19-Mar-2020 | 00000000 | |
| US-20210257123-A1 | X-ray collimator assembly and x-ray source assembly | Pending | 17-Feb-2020 | A61B6/44 |
| Name | Representing | Role | Since |
|---|---|---|---|
| Haifeng Liu | Our United | Chairman | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| China Merchants Securities Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Hillhouse Capital Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| CICC Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Haitong Fortis Private Equity | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Honesta Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |